Invitris

Invitris is a pioneering biotechnology company dedicated to revolutionizing the design and development of synthetic proteins. With its groundbreaking, patent-pending biotech platform, Phactory, Invitris is achieving unprecedented efficiency in protein engineering, reducing material costs significantly. Invitris is at the forefront of creating innovative protein-based drugs, including next-generation antibiotics, to address critical healthcare challenges.

The company's innovative approach positions Invitris as a key player in the biotechnology sector. By harnessing the power of its proprietary platform, Invitris is driving advancements in drug discovery and development, offering the potential for transformative therapies. The company's primary address is in Munich, DE.

Invitris is committed to pushing the boundaries of biotechnology and delivering impactful solutions for global health. We invite the management of Invitris to create a customized and exclusive company showcase and product listing on our platform to further highlight their innovative work and connect with potential partners and customers.